Joe Eron

1.3k total citations
12 papers, 703 citations indexed

About

Joe Eron is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Joe Eron has authored 12 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Joe Eron's work include HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (8 papers) and HIV/AIDS drug development and treatment (7 papers). Joe Eron is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (8 papers) and HIV/AIDS drug development and treatment (7 papers). Joe Eron collaborates with scholars based in United States, South Africa and Malawi. Joe Eron's co-authors include Christopher B. Hurt, Brandyn Lau, M. S. Saag, Taha E. Taha, Irving Hoffman, Stephen R. Cole, Charles Jere, Hrishikesh Chakraborty, John R. Dyer and Johnstone Kumwenda and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Epidemiology and AIDS.

In The Last Decade

Joe Eron

12 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joe Eron United States 9 509 398 224 116 109 12 703
Sigal Yawetz United States 14 340 0.7× 130 0.3× 234 1.0× 159 1.4× 131 1.2× 26 656
Georgette Adjorlolo-Johnson United States 11 393 0.8× 229 0.6× 232 1.0× 61 0.5× 57 0.5× 14 518
Chureeratana Bowonwatanuwong Thailand 14 830 1.6× 377 0.9× 213 1.0× 151 1.3× 265 2.4× 24 960
Laura Camoni Italy 15 377 0.7× 155 0.4× 371 1.7× 82 0.7× 46 0.4× 56 597
Eugène Kroon Thailand 20 874 1.7× 838 2.1× 310 1.4× 197 1.7× 92 0.8× 68 1.1k
Ibra Ndoye Senegal 14 431 0.8× 254 0.6× 300 1.3× 85 0.7× 44 0.4× 26 653
Dorthe Raben Denmark 13 581 1.1× 309 0.8× 535 2.4× 63 0.5× 40 0.4× 30 758
Breno Santos Brazil 16 441 0.9× 161 0.4× 324 1.4× 90 0.8× 72 0.7× 60 688
Adrien Sawadogo Burkina Faso 13 381 0.7× 267 0.7× 324 1.4× 55 0.5× 26 0.2× 27 612
Luisa Galli Italy 12 612 1.2× 440 1.1× 313 1.4× 245 2.1× 54 0.5× 20 803

Countries citing papers authored by Joe Eron

Since Specialization
Citations

This map shows the geographic impact of Joe Eron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joe Eron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joe Eron more than expected).

Fields of papers citing papers by Joe Eron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joe Eron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joe Eron. The network helps show where Joe Eron may publish in the future.

Co-authorship network of co-authors of Joe Eron

This figure shows the co-authorship network connecting the top 25 collaborators of Joe Eron. A scholar is included among the top collaborators of Joe Eron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joe Eron. Joe Eron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Tolley, Elizabeth E., Sahar Z. Zangeneh, Gordon Chau, et al.. (2020). Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077. AIDS and Behavior. 24(9). 2520–2531. 58 indexed citations
4.
Robertson, K. R., et al.. (2020). Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance. UNC Libraries. 1 indexed citations
5.
Gay, Cynthia L., JoAnn Kuruc, Shane D. Falcinelli, et al.. (2019). The impact of vorinostat and AGS-004, a dendritic cell-based immunotherapy, on persistent HIV-1 Infection. Journal of Virus Eradication. 5. 23–23. 1 indexed citations
6.
Gopal, Satish, Chad J. Achenbach, Elizabeth L. Yanik, et al.. (2014). Lymphoma Immune Reconstitution Inflammatory Syndrome in the Center for AIDS Research Network of Integrated Clinical Systems Cohort. Clinical Infectious Diseases. 59(2). 279–286. 29 indexed citations
7.
Hurt, Christopher B., et al.. (2011). Pre-Exposure Prophylaxis and Antiretroviral Resistance: HIV Prevention at a Cost?. Clinical Infectious Diseases. 53(12). 1265–1270. 77 indexed citations
8.
Mugavero, Michael J., Sonia Napravnik, S. R. Cole, et al.. (2011). Viremia Copy-Years Predicts Mortality Among Treatment-Naive HIV-Infected Patients Initiating Antiretroviral Therapy. Clinical Infectious Diseases. 53(9). 927–935. 106 indexed citations
9.
Taiwo, Babafemi, Charles B. Hicks, & Joe Eron. (2010). Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1. Journal of Antimicrobial Chemotherapy. 65(6). 1100–1107. 37 indexed citations
10.
Cole, Stephen R., et al.. (2009). Copy-Years Viremia as a Measure of Cumulative Human Immunodeficiency Virus Viral Burden. American Journal of Epidemiology. 171(2). 198–205. 85 indexed citations
11.
Eron, Joe, Charles B. Hicks, Kara McGee, et al.. (2009). Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina. 4 indexed citations
12.
Hoffman, Irving, Charles Jere, Terrie E. Taylor, et al.. (1999). The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS. 13(4). 487–494. 194 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026